|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.95 AUD | +1.70% |
|
+3.93% | +4.63% |
| Capitalization | 8.27B 5.56B 4.76B 4.42B 4.12B 7.71B 501B 50.96B 20.03B 240B 20.83B 20.41B 878B | P/E ratio 2026 * |
26.4x | P/E ratio 2027 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise value | 15.39B 10.34B 8.86B 8.24B 7.68B 14.35B 932B 94.88B 37.3B 446B 38.79B 37.99B 1,635B | EV / Sales 2026 * |
0.81x | EV / Sales 2027 * | 0.77x |
| Free-Float |
78.44% | Yield 2026 * |
2.41% | Yield 2027 * | 2.87% |
Last Transcript: Ramsay Health Care Limited
| 1 day | +1.70% | ||
| 1 week | +3.93% | ||
| Current month | +4.63% | ||
| 1 month | +1.64% | ||
| 3 months | +11.44% | ||
| 6 months | -5.12% | ||
| Current year | +4.63% |
| 1 week | 34.53 |  | 36 |
| 1 month | 33.78 | | 36 |
| Current year | 34.38 | | 36 |
| 1 year | 30.39 | | 39.84 |
| 3 years | 30.39 | | 69.66 |
| 5 years | 30.39 | | 84.58 |
| 10 years | 30.39 | | 84.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Natalie Davis
CEO | Chief Executive Officer | - | - |
Anthony Neilson
DFI | Director of Finance/CFO | 55 | 23/11/2025 |
John Doulis
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Siddle
CHM | Chairman | - | 26/05/2014 |
David Thodey
CHM | Chairman | 72 | 27/11/2023 |
Catriona Deans
BRD | Director/Board Member | 58 | 14/11/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 0.9% | 1 M€ | |
| -.--% | 0.9% | 0 M€ | |
| +0.59% | 0.28% | 26 M€ | |
| +2.08% | 0.2% | 1,096 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.70% | +3.93% | +6.52% | -46.12% | 5.43B | |
| +0.23% | -0.58% | +21.10% | +43.46% | 18.5B | |
| +0.97% | +4.01% | -5.23% | -53.26% | 15.21B | |
| +0.17% | +2.62% | +6.27% | +66.72% | 11.56B | |
| -0.15% | -4.54% | +11.10% | +70.11% | 10.36B | |
| +1.39% | -0.88% | +32.21% | +79.00% | 10B | |
| -4.23% | -6.22% | -23.63% | -40.17% | 9.57B | |
| -0.77% | +1.18% | -24.85% | - | 7.83B | |
| -1.08% | -2.42% | +34.79% | +215.65% | 7.56B | |
| -1.29% | -1.50% | +47.29% | +155.17% | 4.27B | |
| Average | -0.32% | -0.51% | +10.56% | +54.51% | 10.03B | |
| Weighted average by Cap. | -0.19% | -0.46% | +8.97% | +42.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19.04B 12.8B 10.96B 10.19B 9.5B 17.75B 1,154B 117B 46.15B 552B 48B 47.01B 2,023B | 19.83B 13.33B 11.41B 10.61B 9.89B 18.49B 1,201B 122B 48.06B 575B 49.98B 48.95B 2,107B |
| Net income | 317M 213M 182M 170M 158M 296M 19.21B 1.95B 768M 9.19B 799M 783M 33.69B | 378M 254M 217M 202M 188M 352M 22.88B 2.33B 915M 10.94B 952M 932M 40.13B |
| Net Debt | 7.12B 4.79B 4.1B 3.81B 3.55B 6.64B 431B 43.92B 17.26B 206B 17.95B 17.59B 757B | 7.04B 4.73B 4.05B 3.77B 3.51B 6.57B 427B 43.43B 17.07B 204B 17.75B 17.39B 748B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 35.95 $ | +1.70% | 280,470 |
| 09/01/26 | 35.35 $ | -0.92% | 385,048 |
| 08/01/26 | 35.68 $ | +2.15% | 392,670 |
| 07/01/26 | 34.93 $ | -0.06% | 441,525 |
| 06/01/26 | 34.95 $ | +0.11% | 412,448 |
Delayed Quote Australian S.E., January 12, 2026 at 05:10 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition